Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Alveolar epithelial cell membrane stabilization refers to the collective mechanisms by which the plasma membrane of alveolar epithelial cells maintains integrity and function, especially in response to mechanical stretch, oxidative stress, or disease-related injury[1][2][5]. Key components include integrin-mediated adhesion to the basement membrane, transmembrane ion channels (such as ENaC, CFTR, Na/K ATPase), and cytoskeletal dynamics. Failure to adequately stabilize the membrane—such as during stress failure from overdistension, hyperoxia, or infection—can contribute to increased permeability, impaired fluid homeostasis, reduced surfactant production, and a heightened risk for conditions such as ARDS and pulmonary edema[1][2][4][5]. While membrane stabilization is critical for lung health, it is not itself a discrete, druggable molecular target; rather, interventions commonly aim at supporting or restoring membrane barrier function by influencing the underlying cellular and molecular mechanisms.
null (but drugs may target ion channels, receptors, or pathways involved in membrane stability, such as antioxidants or modulators of ion transport)[2][5]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Alveolar epithelial cell membrane stabilization.